Bristol-Myers Squibb to Take Part in Citi 2013 Global Health Care Conference

NEW YORK--()--Bristol-Myers Squibb Company (NYSE: BMY) will take part in the Citi 2013 Global Health Care Conference on Monday, February 25, 2013, in New York. Giovanni Caforio, president, U.S. Pharmaceuticals will answer questions about the company at 2:15 p.m. ET.

Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. An archived edition of the session will be available later that day.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit www.bms.com or follow us on Twitter at http://twitter.com/bmsnews.

Contacts

Bristol-Myers Squibb Company
Media:
Jennifer Fron Mauer, 609-252-6579
jennifer.mauer@bms.com
or
Investors:
John Elicker, 609-252-4611
john.elicker@bms.com

Release Summary

Bristol-Myers Squibb to Take Part in Citi 2013 Global Health Care Conference.

Contacts

Bristol-Myers Squibb Company
Media:
Jennifer Fron Mauer, 609-252-6579
jennifer.mauer@bms.com
or
Investors:
John Elicker, 609-252-4611
john.elicker@bms.com